Scarica l'app Stockscreener
9.32
2.10%
-0.20
Pre-mercato:
9.31
-0.010
-0.11%
Precedente Chiudi:
$9.52
Aprire:
$9.5
Volume 24 ore:
2.56M
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.26B
Reddito:
-
Utile/perdita netta:
$-287.41M
Rapporto P/E:
-3.0515
EPS:
-3.0542
Flusso di cassa netto:
$-157.61M
1 W Prestazione:
+10.43%
1M Prestazione:
+60.97%
6M Prestazione:
+69.76%
1 anno Prestazione:
+130.69%
Intervallo 1D:
$9.12
$9.571
Intervallo di 1 settimana:
$8.22
$9.625
Portata 52W:
$2.25
$10.21
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Nome
Compass Pathways Plc Adr
Settore
Industria
Telefono
1-716-676-6461
Indirizzo
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, EHC, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
9.32 | 1.26B | 0 | -287.41M | -157.61M | -3.0542 |
HCA
Hca Healthcare Inc
|
428.79 | 95.12B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
186.91 | 16.10B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
20.19 | 11.03B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.16 | 10.43B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
157.04 | 10.36B | 13.64B | 1.05B | 1.31B | 9.555 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | B. Riley Securities | Buy |
| 2025-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-23 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-02-27 | Iniziato | Stifel | Buy |
| 2024-07-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-01 | Iniziato | Morgan Stanley | Overweight |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2022-11-21 | Ripresa | Berenberg | Buy |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2021-10-29 | Iniziato | Oppenheimer | Outperform |
| 2021-07-13 | Iniziato | Citigroup | Buy |
| 2021-06-28 | Iniziato | Maxim Group | Buy |
| 2021-05-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-01 | Iniziato | ROTH Capital | Buy |
| 2020-10-14 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-13 | Iniziato | Berenberg | Buy |
| 2020-10-13 | Iniziato | Canaccord Genuity | Buy |
| 2020-10-13 | Iniziato | Cowen | Outperform |
| 2020-10-13 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Compass Pathways Plc Adr Borsa (CMPS) Ultime notizie
What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN
symbol__ Stock Quote Price and Forecast - CNN
These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat
CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill
BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart
Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance
These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com
Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN
This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa
Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat
Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa
FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India
FDA grants priority voucher to Compass for psilocybin treatment - Investing.com
Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What's Going On With Enveric Biosciences Stock On Friday? - Sahm
Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat
How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN
Compass Pathways (NASDAQ:CMPS) Shares Down 7.3%Should You Sell? - MarketBeat
What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now? - Yahoo Finance
How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136% - sharewise.com
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On? - Sahm
Compass Pathways partners with Osmind on psychedelic treatment delivery By Investing.com - Investing.com South Africa
Compass Pathways partners with Osmind on psychedelic treatment delivery - Investing.com
Compass Pathways (NASDAQ:CMPS) Hits New 1-Year HighHere's What Happened - MarketBeat
Company News for Apr 21, 2026 - Yahoo Finance UK
This 4/20, Wall Street Is Betting on More Than Marijuana - MarketBeat
Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? - Barchart
Compass Pathways (NASDAQ:CMPS) Shares Gap UpHere's Why - MarketBeat
Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga
Investors Purchase Large Volume of Call Options on Compass Pathways (NASDAQ:CMPS) - MarketBeat
Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' - Sahm
Compass Pathways : Notice of 2026 AGM - marketscreener.com
Short Interest in Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Rises By 39.5% - MarketBeat
Board-backed 2026 AGM agenda set at Compass Pathways (NASDAQ: CMPS) - Stock Titan
Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling NDA and 2026 Launch Readiness - Yahoo Finance
Compass Pathways opens grant program for psilocybin training - Investing.com
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
COMPASS Pathways stock: Why psychedelic therapy potential draws investors now - AD HOC NEWS
Compass Pathways Plc Adr Azioni (CMPS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):